Product Information
PREVACID DR 30 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $13.2175 per EA under NDC 64764004613. Its NADAC has been published 578 times since Nov 28, 2013.
FDA first approved this application on May 10, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764004613
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA020406FDA Approved
5/10/1995
TE Code
AB
On Market Since
5/10/1995
Pharmacological Classes
Price Statistics
The NADAC for PREVACID DR 30 MG CAPSULE has been published 578 times since Nov 28, 2013, and over the history we have for it it has risen 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.2175 per EA |
|---|---|
| All-time high | $13.3467 (Oct 10, 2018) |
| All-time low | $8.2070 (Nov 28, 2013) |
| 52-week high | $13.2593 |
| 52-week low | $13.2142 |
| Median price | $13.2300 |
| Average price | $12.5296 |
| Largest weekly change | +9.9% (Oct 15, 2014) |
| Weeks tracked | 578 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREVACID DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREVACID DR 30 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $13.2175 per EA (NDC 64764004613), effective Aug 19, 2026.
How has the price of PREVACID DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREVACID DR 30 MG CAPSULE has risen 61.1%. It has been tracked across 578 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREVACID DR 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PREVACID DR 30 MG CAPSULE has ranged from a low of $8.2070 (Nov 28, 2013) to a high of $13.3467 (Oct 10, 2018), with a median of $13.2300 per EA.
Are there cheaper alternatives to PREVACID DR 30 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG CAPSULE, is $0.1071 per EA — about 99% below PREVACID DR 30 MG CAPSULE.
Who manufactures PREVACID DR 30 MG CAPSULE?
PREVACID DR 30 MG CAPSULE (NDC 64764004613) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.